All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for CENTRIENT PHARMACEUTICALS LLC · Pharmaceutical Manufacturing

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · Senate · $80,000.00 income · posted Jan 20, 2026

Official filing document

Lobbying activity 6

Health Issues

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Pharmacy

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Manufacturing

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Defense

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States; Issues related to the Defense Production Act (P.L. 81-774).

Budget/Appropriations

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Trade (domestic/foreign)

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem